http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CZ-278998-A3

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7c9391dc4b6011e7e181a5f46f6d807b
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K41-0071
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-409
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K41-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-409
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-127
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K41-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-02
filingDate 1997-02-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3dbe06437532dbcc6eb3cf8859baeb7c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a28a96c3560fb47c9e36ed5ccf8fe678
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_74ca53b61adf7c6e836f841a4dbc77fc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bd6aa16771b0f74af7e943d4477cb098
publicationDate 1999-05-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CZ-278998-A3
titleOfInvention A method for improving vision through photodynamic therapy of the eye
abstract Photodynamic therapy of conditions of the eye, especially those conditions characterized by unwanted neovasculature, such as age-related macular degeneration, results in enhanced visual acuity for treated subjects.
priorityDate 1996-03-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID137
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559516
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414867606
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID454973655
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410453302
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID66868
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3086257
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID313
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393789
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449147235
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419549149
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419558200
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID154438332
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID433567920
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID485223053
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11103
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6683
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID148242732
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397365

Total number of triples: 49.